Home Gilead: What's Ahead In 2015 For This Biotech Juggernaut
 

Keywords :   


Gilead: What's Ahead In 2015 For This Biotech Juggernaut

2014-12-21 00:05:58| Biotech - Topix.net

Biotech juggernaut Gilead Sciences has provided its shareholders with better than a 30% gain in 2014 so far as we head into the end of the year. Although the stock has spent the last three months consolidating those gains in a relatively narrow trading range, the direction for 2015 remains up.

Tags: ahead biotech juggernaut gilead

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.09This Week in Agribusiness, September 28, 2024
28.09This Week in Agribusiness, September 28, 2024
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Graphics
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
More »